Our Spruce Pine location is temporarily closed. For continued patient care and new patient referrals, our physicians and staff remain fully available at nearby locations to accommodate appointments, support care, and answer questions as needed. We appreciate your understanding and patience during this time.

For new appointments call 833.758.0023

Optune®

Messino Cancer Centers is now certified to prescribe Optune® for the treatment of newly diagnosed and recurrent glioblastoma (GBM). This wearable and portable medical device is the first FDA-approved treatment in more than a decade for newly diagnosed GBM.

How it works

Optune creates low-intensity alternating electric fields – called Tumor Treating Fields (TTFields) – which potentially slow or stop cell division leading to cell death. Because TTFields do not enter the bloodstream like a drug, TMZ (temozolomide chemotherapy)-related side effects for newly diagnosed patients can be minimized. In clinical trials the most common device related adverse events when using Optune alone were scalp irritation from device use and headache.